Inventor · disambiguated record
Matthias Stephan
Also filed as: STEPHAN MATTHIAS
13 granted patents·14 pending applications·518 citations·filing 2008–2025
92Inventor score
Files withHUTCHINSON FRED CANCER RES9FRED HUTCHINSON CANCER CENTER7MASSACHUSETTS INST TECHNOLOGY4MEMORIAL SLOAN KETTERING CANCER CENTER3SADELAIN MICHEL2
Top patents by PatentIndex Score
27 records- 0197US8389282B2Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytesSADELAIN MICHEL·Filed 2008·Granted Mar 5, 2013·412 cites·18 claims
- 0296US9220728B2Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytesSADELAIN MICHEL·Filed 2012·Granted Dec 29, 2015·42 cites·30 claims
- 0394US9393199B2Methods and compositions for localized agent deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Jul 19, 2016·15 cites·66 claims
- 0493US10702551B2Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapseHUTCHINSON FRED CANCER RES·Filed 2018·Granted Jul 7, 2020·6 cites·9 claims
- 0593US10117897B2Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Nov 6, 2018·13 cites·26 claims
- 0691US10392446B2Compositions and methods to modify cells for therapeutic objectivesHUTCHINSON FRED CANCER RES·Filed 2017·Granted Aug 27, 2019·4 cites·16 claims
- 0791US9283184B2Methods and compositions for localized agent deliveryIRVINE DARRELL J·Filed 2009·Granted Mar 15, 2016·14 cites·25 claims
- 0889US10188749B2Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriersHUTCHINSON FRED CANCER RES·Filed 2017·Granted Jan 29, 2019·9 cites·8 claims
- 0986US11890303B2Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapseFRED HUTCHINSON CANCER CENTER·Filed 2020·Granted Feb 6, 2024·1 cites·19 claims
- 1078US11566061B2Systems and methods to improve vaccine efficacyFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Jan 31, 2023·1 cites·28 claims
- 1177US11872195B2Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriersFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Jan 16, 2024·1 cites·19 claims
- 1275US2024033293A1Scaffolds to treat solid tumor cells and escape variantsFRED HUTCHINSON CANCER CENTER·Filed 2023·Application pending·0 cites
- 1374US2022016170A1Constitutive expression of costimulatory ligands on adoptively transferred t lymphocytesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 1473US11077140B2Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Aug 3, 2021·0 cites·15 claims
- 1572US10806756B2Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapseHUTCHINSON FRED CANCER RES·Filed 2018·Granted Oct 20, 2020·0 cites·20 claims
- 1672US2025188191A1Compositions and methods to modify cells for therapeutic objectivesFred Hutchison Cancer Center·Filed 2025·Application pending·0 cites
- 1772US2019330373A1Compositions and methods to modify cells for therapeutic objectivesHUTCHINSON FRED CANCER RES·Filed 2019·Application pending·0 cites
- 1870US2021259968A1Methods and compositions for localized agent deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Application pending·0 cites
- 1969US2016008399A1Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapseHUTCHINSON FRED CANCER RES·Filed 2014·Application pending·0 cites
- 2069US2023312674A1Systems and methods to improve vaccine efficacyFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 2168US2016145348A1Compositions and methods to modify cells for therapeutic objectivesHUTCHINSON FRED CANCER RES·Filed 2014·Application pending·0 cites
- 2263US2024285797A1Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarrierFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 2363US2016256386A1Methods and compositions for localized agent deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Application pending·0 cites
- 2458US2018110733A1Methods and compositions for localized agent deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Application pending·0 cites
- 2554US2023331804A1Nanoparticle systems to stimulate and maintain immune system responsiveness at treatment sitesFRED HUTCHINSON CANCER CENTER·Filed 2020·Application pending·0 cites
- 2654US2019336532A1Scaffolds to treat solid tumor cells and escape variantsHUTCHINSON FRED CANCER RES·Filed 2017·Application pending·0 cites
- 2751US2021128485A1Nanoparticles for gene expression and uses thereofHUTCHINSON FRED CANCER RES·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthias Stephan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →